Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis

• Published in: European journal of nuclear medicine and molecular imaging 2021-11, Vol.48 (12), p.3886-3902
• Main Authors: van der Geest, K. S. M., Treglia, G., Glaudemans, A. W. J. M., Brouwer, E., Sandovici, M., Jamar, F., Gheysens, O., Slart, R. H. J. A.
• Format: Article
• Language: English
• Subjects: Arteritis; Bivariate analysis; Cardiology; Clinical aspects; Computed tomography; Cross-Sectional Studies; Fluorine isotopes; Fluorodeoxyglucose F18; Health services; Heterogeneity; Humans; Imaging; Infection and inflammation; Medical diagnosis; Medicine; Medicine & Public Health; Meta-analysis; Monitoring; Nuclear Medicine; Oncology; Orthopedics; Patients; Positron emission; Positron emission tomography; Positron Emission Tomography Computed Tomography; Radiology; Radiopharmaceuticals; Remission; Remission (Medicine); Review; Review Article; Systematic review; Takayasu's disease; Telemedicine; Tomography; Vasculitis; Vein & artery diseases
• ISSN: 1619-7070; 1619-7089
• DOI: 10.1007/s00259-021-05362-8

Purpose Monitoring disease activity in patients with large vessel vasculitis (LVV) can be challenging. [18F]FDG-PET/CT is increasingly used to evaluate treatment response in LVV. In this systematic review and meta-analysis, we aimed to summarize the current evidence on the value of [18F]FDG-PET/CT for treatment monitoring in LVV. Methods PubMed/MEDLINE and the Cochrane library database were searched from inception through October 21, 2020. Studies containing patients with LVV (i.e. giant cell arteritis, Takayasu arteritis and isolated aortitis) that received treatment and underwent [18F]FDG-PET/CT were included. Screening, full-text review and data extraction were performed by 2 investigators. The risk of bias was examined with the QUADAS-2 tool. Meta-analysis of proportions and diagnostic test accuracy was performed by a random-effects model and bivariate model, respectively. Results Twenty-one studies were included in the systematic review, of which 8 studies were eligible for meta-analysis. Arterial [18F]FDG uptake decreased upon clinical remission in longitudinal studies. High heterogeneity ( I 2 statistic 94%) precluded meta-analysis of the proportion of patients in which the scan normalized during clinical remission. Meta-analysis of cross-sectional studies indicated that [18F]FDG-PET/CT may detect relapsing/refractory disease with a sensitivity of 77% (95%CI 57–90%) and specificity of 71% (95%CI 47–87%). Substantial heterogeneity was observed among the cross-sectional studies. Both variation in clinical aspects and imaging procedures contributed to the heterogeneity. Conclusion Treatment of LVV leads to reduction of arterial [18F]FDG uptake during clinical remission. [18F]FDG-PET/CT has moderate diagnostic accuracy for detecting active LVV. [18F]FDG-PET/CT may aid treatment monitoring in LVV, but its findings should be interpreted in the context of the clinical suspicion of disease activity. This study underlines the relevance of published procedural recommendations for the use of [18F]FDG-PET/CT in LVV.